sulforaphane has been researched along with Carcinoid Tumor in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bronchial carcinoids are neuroendocrine tumors that present as typical (TC) and atypical (AC) variants, the latter being more aggressive, invasive and metastatic." | 5.51 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. ( Baluch, N; Bayat Mokhtari, R; Cheng, HL; Das, B; Kumar, S; Morgatskaya, E; Muscarella, LA; Sparaneo, A; Yeger, H; Zhao, S, 2019) |
| "Bronchial carcinoids are neuroendocrine tumors that present as typical (TC) and atypical (AC) variants, the latter being more aggressive, invasive and metastatic." | 1.51 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. ( Baluch, N; Bayat Mokhtari, R; Cheng, HL; Das, B; Kumar, S; Morgatskaya, E; Muscarella, LA; Sparaneo, A; Yeger, H; Zhao, S, 2019) |
| "In vitro studies were used for the dose-response (AlamarBlue) effects of acetazolamide (AZ) and sulforaphane (SFN) on clonogenicity, serotonin-induced growth effect and serotonin content (LC-MS) on H-727 (TC) and H-720 (AC) bronchial carcinoid cell lines and their derived NOD/SCID mice subcutaneous xenografts." | 1.39 | Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines. ( Adeli, K; Cutz, E; Islam, SS; Kumar, S; Mokhtari, RB; Yazdanpanah, M; Yeger, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayat Mokhtari, R | 1 |
| Baluch, N | 1 |
| Morgatskaya, E | 1 |
| Kumar, S | 2 |
| Sparaneo, A | 1 |
| Muscarella, LA | 1 |
| Zhao, S | 1 |
| Cheng, HL | 1 |
| Das, B | 1 |
| Yeger, H | 2 |
| Mokhtari, RB | 1 |
| Islam, SS | 1 |
| Yazdanpanah, M | 1 |
| Adeli, K | 1 |
| Cutz, E | 1 |
2 other studies available for sulforaphane and Carcinoid Tumor
| Article | Year |
|---|---|
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane.
Topics: Acetazolamide; Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Bro | 2019 |
Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.
Topics: Acetazolamide; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carbonic Anhydrase Inhibitors; C | 2013 |